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.Summary In patients with coronary artery disease (CAD) the prevalence of
obstructive sleep apnoea (OSA) is found to be about 14–65%. In this study, the
influence of OSA in 50 patients with CAD was prospectively compared during a
follow-up period of 10 years. In the follow-up period 4 of 25 patients with OSA and 5
of the 25 without OSA died by cardiovascular complications. The proportion survival
curve showed no significant difference for patients with CAD and with versus without
OSA. The results of this rather small 10-year follow-up study failed to give further
evidence for an increased mortality in patients with CAD and OSA.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Mortality from coronary artery disease (CAD) shows
a decline attributed to improvements in treatment
of CAD and in prevention. Still, the mortality rate
remains high in this group of patients. Retro-
spective studies found an apnoea–hypopnoea index
to be an independent predictor for myocardial
infarction in obstructive sleep apnoea (OSA).1–3 The
prevalence of OSA is found to be about 14–65% in
CAD.2–6 The first prospective study so far investi-
gating the cardiovascular mortality in CAD patients
with versus without concomitant OSA in a 5-year
follow-up was published by Peker et al.7 In thisElsevier Ltd. All rights reserv
1 2866462.
d.uni-marburg.destudy, OSA, defined as a respiratory disturbance
index of 10/h or more was found in 19 of 62
patients. The follow-up revealed an increased risk
for untreated OSA of cardiovascular death in
patients with CAD.
To confirm this we investigated cardiovascular
complications in patients with CAD with versus
without OSA in a 10-year follow-up. In our analysis
OSA was defined as an apnoea index (AI) 410/h
according to study criteria from the previously
published prevalence study.6Methods
In the initial overnight study, 50 patients with
angiographical provided diagnosis of CAD wereed.
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Figure 1 Proportional surviving of OSA versus non-OSA.
The figure shows the number of deceased patients during
the follow-up period of 10 years. Patients deceased due
to malignant diseases were censored.
Influence of OSA in CAD 181randomly included (47 men, 3 women; mean age
61+6 years). The selection criteria were an angio-
graphical diagnosed CAD with a stenosis of one or
more coronary vessels of at least 50%. A left
ventricular ejection fraction of less than 40%, an
age of more than 70 years and a history of cerebral
infarction were exclusion criteria.6
The patients included were primarily investiga-
ted by a non-laboratory-monitoring-system (SGT24B,
Fa. Jaeger, Wuerzburg, Germany). Twenty-five
patients of the included 50 patients showed an AI
410/h with obstructive pattern. The OSA-group had
an AI of 19.4+6.7/h compared to an AI of 5.1+2.3/h
in the non-OSA-group (Po0:00001) (Table 1).
In the baseline OSA-group 19 of the 25 patients
participated in a full night polysomnography. In this
patient group the AI was 17.0+10.9/h and the
apnoea–hypopnoea index was 32.4+16.5/h sleep.
Twelve of the 19 polysomnographic controlled
patients were recommended to have a continuous
positive airway pressure therapy (CPAP). While 5
denied from the beginning, 7 at first tried the
therapy option but stopped during the follow-up
period. No patient continued CPAP during the
complete follow-up period.
For follow-up the patients were contacted and
had a request about their medical history during
the past time period 10 years after the first sleep
study. Those patients that survived and who agreed
again were investigated by non-laboratory-moni-
toring-system for air flow, heart rate, body position
and oxygen saturation as well as by echocardio-
graphy.
Student’s t-test or the Mann–Whitney U-test
were used for variables measured on a continuous
scale. Categorical variables were compared by the
chi-square test or Fisher exact test (two-tailed).
Continuous values are given as mean7SD. Survival
analyses were performed by the Kaplan–Meier
method and statistical comparison by the Log-rank
test. A P value of 0.05 or less was regarded as
statistically significant.Table 1 Differences in baseline characteristics from OSA
OSA (n ¼ 25)
Age (years) 63.173.5
BMI (kg/m2) 27.874.2
AI (/h) 19.476.7
Hypertension (n) 13
3-vessel-CAD (%) 20
BMI ¼ body mass index; AI ¼ apnoea index; 3-vessel-CAD ¼ 3 vess
or Chi-squared test.Results
Fifteen patients refused further investigation dur-
ing the follow-up, but for all patients the history of
cardiovascular events and death could be obtained.
After a time interval of 10 years 4 patients had died
in the OSA-group and 8 in the non-OSA-group. Three
patients in the non-OSA-group died due to malig-
nant tumor and 5 due to cardiovascular disease
while the 4 patients in the OSA-group died due to
cardiovascular disease (P ¼ ns). The proportion of
the OSA-group to the non-OSA-group regarding
survival time shows no significant increased risk
(log-rank test) of cardiovascular complications in
OSA-patients (P ¼ ns) (Fig. 1).- and non-OSA-patients.
Non-OSA (n ¼ 25) P values
58.477.2 o0.02
25.773.0 o0.05
5.172.3 o0.00001
7 o0.05
48 o0.08
el coronary artery disease; P values by Mann–Whitney U-test
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complications regarding myocardial infarction and
cerebral insult during 10-year follow-up were 5 in
the initial OSA-group versus 2 in the non-OSA-group
(P ¼ ns). Cardiac interventions like catheterization
or bypass-surgery where performed in 13 patients
of the non-OSA-group and in 11 of the OSA-group
(P ¼ ns).
No significant differences were found for initial
or follow-up medical treatments between the OSA-
group and the non-OSA-group.
For only 26 of the initial 50 patients a follow-up
investigation could be performed. From these 26
patients 10 changed their profiles as patients with
or without OSA according to study criteria. Seven of
those 10 patients had less obstructive apnoeas and
only 3 had more than 10/h. These recorded shifts
did not result in significant differences for surviving
proportion.Discussion
The first prospective investigation of the impact of
OSA on cardiovascular mortality was performed by
Peker et al.7 In Peker’s study cardiovascular
mortality could be independently related to the
respiratory disturbance index. Mooe and colleagues
also showed a correlation of an oxygen desaturation
index of 45/h in sleep disordered breathing to
increased cardiac risk in a 5-year follow-up.1 This
was in concordance with the results of earlier
retrospective studies.2,8,9 In our investigation the
number of patients included in the study was small,
but this is the first follow-up for a 10-year period.
According to our results the influence of OSA does
not appear to be a factor explaining an increased
mortality in CAD. Although cofactors like body-mass
index, hypertension and age have not been
matched for both OSA- and non-OSA-patients in
the initial study population as listed above there
was no significant difference for cardiovascular
mortality. In concordance with our findings an AHI
410/h has also been missing significance in primary
end point in the 408 patients of Mooe’s study
population.1 Mooe and coworkers did not distin-
guish the different apnoea types. A possible reason
in our study may have been the different severity of
CAD in both groups with a tendency to more severe
CAD in the initial non-OSA-group (P ¼ 0:08). In
Mooe’s study population poor left ventricular
function was more common in patients with sleep
disordered breathing.1As we performed a second evaluation for sleep
apnoea in 26 of the initial study patients an
interesting aspect of this study is the high rate of
group shifts from OSA to non-OSA and vice versa.
Ten of the 26 patients with a second investigation
changed their status, mainly from OSA to non-OSA.
These recorded shifts did not result in significant
differences for surviving proportion.
For the initial medical treatment a significant
rise in cardiac medications during follow-up can be
stated. Since the start of modifications in medica-
tion was not referred during follow-up there is no
way to emphasize possible interferences in the 10
years of follow-up. In the study population of Peker
and coworkers the patients with OSA tended to use
more cardiac medications. This could have been
reasoned by a more severe cardiac failure in the
OSA-group. Echocardiographic data of the patients
in Peker’s study were not completely obtained so
severity of cardiac failure cannot be definitively
stated.
In conclusion, we missed a significant influence of
OSA in CAD in our small patient group although the
evidence of an influence is growing due to several
investigations.1,3,7 Possibly, the relationship has
been overemphasized in previous studies. Still a
prospective and adequate sample sized study with
matched patient groups for severity of heart
disease has to be performed.References
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